<unk>  is a direct thrombin inhibitor that is FDA approved for the prophylaxis of patients undergoing percutaneous transluminal coronary angioplasty (PTCA) and patients with unstable angina or risk of heparin induced thrombocytopenia (HIT) undergoing percutaneous coronary intervention (PCI)..   Common adverse reactions include bleeding, headache, thrombocytopenia and fever.
Bivalirudin
Hirudin
Desirudin
Lepirudin 
Otamixaban
Argatroban
Lusutrombopag
Avatrombopag